Russia licensed it based on early trials involving only 76 people, whereas usually most approvals come after Phase 3 studies involving tens of
thousands of subjects....
"I see no reason to doubt it [the results]," Jones told CBC News in an interview. "I agree that their initial results caused consternation, but I
don't think it's because they weren't valid. They were released a bit soon... We do not know how carefully their trials are monitored and how
carefully they are reported. We do not know that," he said.
...the claim of 91.4 per cent success is based on just 39 people in the 18,000-person sample contracting COVID-19. The sample is too low to claim any
percentage of efficacy, Bucci told CBC News.
Furthermore, he said, it's not clear where these 39 people came from, how old they were and whether the results from trials in one country were mixed
with those from another location.
...initial estimates that Russia would be able to produce 200 million doses of Sputnik V by the end of next month [i.e. December] turned out to be
wildly optimistic. The health ministry now says it may be able produce two million doses, at best.
Putin himself has not [agreed to get vaccinated with Sputnik V]. A spokesperson said it would be irresponsible for the head of state to take an
"uncertified" vaccine.
|
